LEADER 05481oam 2200469 450 001 9910483567203321 005 20210626121205.0 010 $a3-030-57915-8 024 7 $a10.1007/978-3-030-57915-9 035 $a(CKB)4900000000508947 035 $a(DE-He213)978-3-030-57915-9 035 $a(MiAaPQ)EBC6468496 035 $a(PPN)253861144 035 $a(EXLCZ)994900000000508947 100 $a20210626d2021 uy 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aManagement of muscle invasive bladder cancer /$fSanchia S. Goonewardene [and five others] 205 $a1st ed. 2021. 210 1$aCham, Switzerland :$cSpringer,$d[2021] 210 4$d©2021 215 $a1 online resource (XXXIX, 590 p. 37 illus. in color.) 225 0 $aManagement of urology 300 $aIncludes index. 311 $a3-030-57914-X 327 $a1. Introduction to muscle invasive bladder cancer -- 2. Epidemiology and risk factors in muscle invasive bladder cancer -- 3. The molecular basis of muscle invasive bladder cancer -- 4. Histological variants in MIBC - squamous cell and squamous differentiation -- 5. Histological variants in muscle invasive bladder cancer ? adenocarcinoma -- 6. Histological variants in muscle invasive bladder Cancer - sarcomatoid cancer -- 7. MIBC Carcinosarcoma -- 8. Muscle invasive bladder cancer- small cell -- 9. MIBC plasmacytoid -- 10. MIBC and micropapillary bladder cancer -- 11. MIBC bladder cancer assessment and diagnosis -- 12. A systematic review on blue light cystoscopy in bladder cancer diagnostics -- 13. A systematic review on the staging conundrum in bladder cancer -- 14. Current state of investigations and limitations in muscle invasive bladder cancer -- 15. Risk stratification in bladder cancer -- 16. Preventative measures for those with high risk MIBC -- 17. Bladder cancer risk post pelvic irradiation -- 18. A systematic review on bladder preservation strategies and MIBC -- 19. Partial cystectomy -- 20. Muscle invasive bladder cancer and neoadjuvant chemotherapy -- 21. Controversies in clinical effectiveness of neoadjuvant chemotherapy -- 22. Trimodal therapy in bladder cancer -- 23. Systematic review on trimodal therapy in bladder cancer -- 24. Trimodal therapy - a systematic review -- 25. Reviews related to trimodal therapy for MIBC -- 26. Radical cystectomy lap open robotic -- 27. Prostate sparing cystectomy - a systematic review -- 28. A systematic review on nerve sparing cystoprostatectomy -- 29. MIBC - orthotopic vs ileal conduit -- 30. MIBC - a systematic review on orthotopic neobladder vs. ileal conduit -- 31. MIBC and radical cystectomy in the elderly -- 32. MIBC radical radiotherapy -- 33. MIBC - quality of life with urinary diversion -- 34. Neoadjuvant chemotherapy for muscle invasive bladder cancer -- 35. Muscle invasive bladder cancer and the staging conundrum -- 36. Radical cystectomy outcomes -- 37. Muscle Invasive bladder cancer and neoadjuvant chemotherapy -- 38. Muscle invasive bladder cancer and the staging conundrum -- 39. Physical pre-habilitation prior to radical cystectomy -- 40. Exercise therapy pre surgery -- 41. Patient fitness for surgery -- 42. CPEX testing prior to major urological surgery -- 43. Cardio-pulmonary exercise testing and major urological surgery -- 44. Robotic radical cystectomy and enhanced recovery -- 45. The robotic approach to redo surgery -- 46. Robotic cystectomy and intracorporeal neobladder formation -- 47. Secondary pelvic malignancies and bladder cancer -- 48. Organ sparing cystectomy -- 49. Robotic radical cystectomy -- 50. Robotic cystectomy and intracorporeal stoma formation -- 51. Orthotopic neobladders vs. ileal conduits -- 52. The role of enhanced recovery in robotic cystectomy -- 53. Robotic radical cystectomy and lymph node dissection -- 54. Robotic cystectomy and sentinel node mapping -- 55. Robotic radical cystectomy and intracorporeal stoma formation -- 56. Lap vs open vs robotic cystectomy -- 57. A systematic review on obesity in bladder cancer -- 58. Systematic review results on obesity in bladder cancer -- 59. Reviews on BMI and bladder cancer -- 60. Survivorship Issues in muscle invasive bladder cancer -- 61. Muscle invasive bladder cancer and health related quality of life -- 62. Body image in bladder cancer -- 63. The rationale for neoadjuvant chemotherapy -- 64. Support for partners in bladder cancer. 330 $aThis book provides a systematic review of the management and treatment of this disease. The concise and highly structured chapters feature essential background knowledge and commentary on recent advances within each step of a range of patient pathways. Management of Muscle Invasive Bladder Cancer provides a framework for patients? care based on the research, as well as practically and clinically oriented guidelines. This book is relevant to trainees and practicing urologists and oncologists, in addition to medical professionals involved in the treatment of bladder cancer. 410 0$aManagement of Urology,$x2730-6372 606 $aBladder$xCancer 615 0$aBladder$xCancer. 676 $a616.99462 700 $aGoonewardene$b Sanchia$01228004 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bUtOrBLW 906 $aBOOK 912 $a9910483567203321 996 $aManagement of muscle invasive bladder cancer$92850997 997 $aUNINA LEADER 04464nam 2201117z- 450 001 9910557141203321 005 20210501 035 $a(CKB)5400000000040647 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/68554 035 $a(oapen)doab68554 035 $a(EXLCZ)995400000000040647 100 $a20202105d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aSample Preparation in Metabolomics 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (208 p.) 311 08$a3-03943-813-1 311 08$a3-03943-814-X 330 $aMetabolomics is increasingly being used to explore the dynamic responses of living systems in biochemical research. The complexity of the metabolome is outstanding, requiring the use of complementary analytical platforms and methods for its quantitative or qualitative profiling. In alignment with the selected analytical approach and the study aim, sample collection and preparation are critical steps that must be carefully selected and optimized to generate high-quality metabolomic data. This book showcases some of the most recent developments in the field of sample preparation for metabolomics studies. Novel technologies presented include electromembrane extraction of polar metabolites from plasma samples and guidelines for the preparation of biospecimens for the analysis with high-resolution ? magic-angle spinning nuclear magnetic resonance (HR-?MAS NMR). In the following chapters, the spotlight is on sample preparation approaches that have been optimized for diverse bioanalytical applications, including the analysis of cell lines, bacteria, single spheroids, extracellular vesicles, human milk, plant natural products and forest trees. 606 $aMedicine and Nursing$2bicssc 610 $a20% FCS 610 $aAMOPLS 610 $aAsPC-1 610 $abiomarkers 610 $acapillary electrophoresis-mass spectrometry 610 $acapillary electrophoresis-mass spectrometry (CE-MS) 610 $acardiovascular disease 610 $acell line 610 $adatabases 610 $adesign of experiments 610 $adiagnostics 610 $adrug discovery 610 $aelectromembrane extraction 610 $aexosomes 610 $aextracellular vesicles 610 $aextraction 610 $aforestry 610 $agas chromatography 610 $agas chromatography-mass spectrometry (GC-MS) 610 $aGC-MS 610 $aharvesting 610 $ahigh resolution mass spectrometry 610 $ahigh-resolution magic angle spinning 610 $ahuman cell line 610 $ahuman milk 610 $ahuman plasma 610 $ahydrophilic interaction liquid chromatography 610 $aion mobility spectrometry 610 $aIT-139 610 $aKP1339 610 $aLC-MS 610 $aLC-MS/MS 610 $alipidomics 610 $aliquid chromatography 610 $aliquid chromatography-mass spectrometry 610 $aliquid chromatography-mass spectrometry (LC-MS) 610 $amass spectrometry 610 $ametabolic pathways 610 $ametabolic profiling 610 $ametabolite extraction 610 $ametabolites 610 $ametabolome 610 $ametabolomics 610 $ametabonomics 610 $ametadata standardization 610 $ametallodrugs 610 $amethod development 610 $aMiaPaCa-2 610 $amicroscopic samples 610 $amicrovesicles 610 $amulti-segment injection 610 $amulticellular tumor spheroids 610 $aNMR 610 $anormalization 610 $anuclear magnetic resonance (NMR) 610 $anuclear magnetic resonance spectroscopy 610 $aoxaliplatin 610 $aPanc-1 610 $aplant metabolomics 610 $aplant natural products 610 $asample preparation 610 $asampling 610 $atrees 615 7$aMedicine and Nursing 700 $aKuligowski$b Julia$4edt$01302968 702 $aQuintás$b Guillermo$4edt 702 $aKuligowski$b Julia$4oth 702 $aQuintás$b Guillermo$4oth 906 $aBOOK 912 $a9910557141203321 996 $aSample Preparation in Metabolomics$93026786 997 $aUNINA